CTRI/2010/091/001400已完成3 期
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients With Schizophrenia. - Nil
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Male or female patients who are 18 to 60 years of age
- •- Patients who have provided informed consent prior to any study specific procedures
- •- Completion of the double-blind treatment period of Study RGH-MD-05
- •- Patients who are eligible to continue as outpatients in the opinion of the Principal Investigator
- •- Patients with normal physical examination, laboratory, vital signs, and or electrocardiogram (ECG)
- •- A designated caregiver to accompany the patient at each visit and who has provided informed consent
排除标准
- •- Positive result from the blood alcohol test or urine drug screen for prohibited medications
- •- Patients who have extrapyramidal symptoms that are not adequately controlled by anti-EPS medications in the opinion of the PI
- •- Patients who are experiencing ongoing, uncontrolled, clinically significant adverse events
研究者
相似试验
进行中（未招募）
不适用
Evaluation of the Long-Term Safety, Tolerability, and Pharmacokinetics of Cariprazine in Patients with SchizophreniaSchizophrenia is a lifelong disabling psychiatric disorder with a reported worldwide prevalence of about 1%.MedDRA version: 12.1Level: LLTClassification code 10001064Term: Acute schizophreniaEUCTR2010-018405-12-LTForest Research Institute, Inc.600
进行中（未招募）
1 期
Study to assess the long-term safety and tolerability of erenumab in migraine patientsMigraine prophylaxisMedDRA version: 20.0Level: PTClassification code 10027599Term: MigraineSystem Organ Class: 10029205 - Nervous system disordersEUCTR2019-002201-22-DEovartis Pharma GmbH640
进行中（未招募）
1 期
Estudio de seguridad y tolerabilidad a largo plazo de la administración abierta Arikace en pacientes con fibrosis quística con infección crónica por Pseudomonas aeruginosaInfeccion pulmonar por Pseudomonas Aeruginosa/ colonizacion en pacientes con fibrosis quisticaMedDRA version: 14.0Level: PTClassification code 10011763Term: Cystic fibrosis lungSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2011-000443-24-ESInsmed Incorporated250
招募中
1 期
Evaluation of the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of PLN-74809Respiratory - Other respiratory disorders / diseasesOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonInflammatory and Immune System - Other inflammatory or immune system disordersPrimary Sclerosing CholangitisIdiopathic pulmonary fibrosisACTRN12620000536965Pliant Therapeutics, Inc.80
进行中（未招募）
1 期
ong Term Follow-up Study of AAVAnc80-hOTOF Gene TherapyOtoferlin gene-mediated hearing lossCTIS2024-512584-31-00Akouos Inc.14